Previous close | 6,452.00 |
Open | 6,493.00 |
Bid | 6,567.00 x 0 |
Ask | 6,592.00 x 0 |
Day's range | 6,493.00 - 6,595.00 |
52-week range | 4,799.00 - 6,845.00 |
Volume | |
Avg. volume | 1,159,781 |
Market cap | 3.573T |
Beta (5Y monthly) | 0.23 |
PE ratio (TTM) | 25.97 |
EPS (TTM) | 253.56 |
Earnings date | 29 July 2024 - 02 Aug 2024 |
Forward dividend & yield | 120.00 (1.82%) |
Ex-dividend date | 27 June 2024 |
1y target est | 6,310.00 |
Per the agreement, Ionis (IONS) will be responsible for the clinical development of the HAE drug. Otsuka will be responsible for all regulatory filings and commercialization activities in Europe.
PALO ALTO, Calif., November 10, 2023--Recor Medical, Inc. announces the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation system for the treatment of hypertension.
PALO ALTO, Calif., November 08, 2023--Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension